ARCHIVES

PV-10 Produces 51 Percent Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

ACS Urges Practice Of Insurance Exclusion End Under Reform

February 5, 1993

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 12, 1974

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award

April 2, 1993

NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion

March 28, 1997